SCHEMBL358689

SCHEMBL358689

CCCCc1ccc(CO)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 2/20 0.59
CA1 P00915 1/20 0.59
ALDH1A1 P00352 3/20 0.57
HSD17B10 Q99714 2/20 0.57
HPGD P15428 1/20 0.57
ESR1 P03372 2/20 0.56
ADRA2A P08913 2/20 0.56
ADORA3 P0DMS8 2/20 0.56
TACR2 P21452 2/20 0.56
SLC6A2 P23975 2/20 0.56
SLC6A4 P31645 2/20 0.56
SLC6A3 Q01959 2/20 0.56
KDM4E B2RXH2 1/20 0.56
LMNA P02545 1/20 0.56
SHBG P04278 1/20 0.56
TP53 P04637 1/20 0.56
CYP3A4 P08684 1/20 0.56
HSPD1 P10809 1/20 0.56
ADRB3 P13945 1/20 0.56
HTR2C P28335 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL357024 0.93 ESR1 (0.65) ALDH1A1HSD17B10ESR1ADRA2AADORA3
SCHEMBL9600021 0.91 ESR1 (0.69) ALDH1A1HSD17B10ESR1ADRA2AADORA3
SCHEMBL359570 0.91 ESR1 (0.69) ALDH1A1HSD17B10ESR1ADRA2AADORA3
SCHEMBL359592 0.91 ESR1 (0.69) ALDH1A1HSD17B10ESR1ADRA2AADORA3
SCHEMBL359311 0.91 ESR1 (0.69) ALDH1A1HSD17B10ESR1ADRA2AADORA3
SCHEMBL7769065 0.91 ESR1 (0.69) ALDH1A1HSD17B10ESR1ADRA2AADORA3
SCHEMBL4297552 0.91 ESR1 (0.69) ALDH1A1HSD17B10ESR1ADRA2AADORA3
SCHEMBL11031408 0.91 ESR1 (0.69) ALDH1A1HSD17B10ESR1ADRA2AADORA3
SCHEMBL176980 0.91 ESR1 (0.69) ALDH1A1HSD17B10ESR1ADRA2AADORA3
SCHEMBL358879 0.91 ESR1 (0.69) ALDH1A1HSD17B10ESR1ADRA2AADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 788 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260060286-A1 A COMPOSITION FOR FAT-SOLUBLE VITAMINS AND PROCESS THEREOF NALAWADE PRAVIN (IN) 2026-03-05 US claimed
US-20250197914-A1 MICROBIAL MEDIUM COMPOSITION FOR PRODUCING RETINOL, COMPRISING ANTI-OXIDANT, AND USE THEREOF CJ CHEILJEDANG CORPORATION (KR) 2025-06-19 US claimed
CN-119570168-A Rubber composition for cleaning scale of mold 贺晓琴 2025-03-07 CN claimed
CN-119487203-A Microbial culture medium composition for producing retinol comprising antioxidant and use thereof CJ第一制糖株式会社 2025-02-18 CN claimed
EP-4491736-A1 MICROBIAL MEDIUM COMPOSITION FOR PRODUCING RETINOL, COMPRISING ANTI-OXIDANT, AND USE THEREOF CJ CheilJedang Corporation (KR) 2025-01-15 EP claimed
CN-117154340-A Polydioxolane solid electrolyte battery diaphragm, preparation method, battery and electrochemical device 湖州南木纳米科技有限公司 2023-12-01 CN claimed
WO-2023199346-A1 A COMPOSITION FOR FAT-SOLUBLE VITAMINS AND PROCESS THEREOF NALAWADE PRAVIN (IN) 2023-10-19 WO claimed
WO-2023182581-A1 MICROBIAL MEDIUM COMPOSITION FOR PRODUCING RETINOL, COMPRISING ANTI-OXIDANT, AND USE THEREOF 씨제이제일제당 (주) 2023-09-28 WO claimed
CN-106588696-B A kind of preparation method of trans- 'alpha ', ' bela '-unsaturated nitrile class compound 西北师范大学 2018-12-25 CN claimed
US-8513326-B2 Carbamate-methacrylate monomers and their use in dental applications SEPTODONT CONFI-DENTAL (US) 2013-08-20 US claimed
EP-2346910-A1 CARBAMATE-METHACRYLATE MONOMERS AND THEIR USE IN DENTAL APPLICATIONS Septodont Confi-Dental Division (US) 2011-07-27 EP claimed
US-20100307378-A1 CARBAMATE-METHACRYLATE MONOMERS AND THEIR USE IN DENTAL APPLICATIONS SEPTODONT CONFI-DENTAL DIVISION (US) 2010-12-09 US claimed
WO-2010042818-A1 CARBAMATE-METHACRYLATE MONOMERS AND THEIR USE IN DENTAL APPLICATIONS SEPTODONT CONFI-DENTAL DIVISION (US) 2010-04-15 WO claimed
US-6989052-B1 Phase change ink printing process XEROX CORPORATION (US) 2006-01-24 US claimed
US-20060004123-A1 PHASE CHANGE INK PRINTING PROCESS XEROX CORPORATION 2006-01-05 US claimed
EP-0191286-B1 SEBOSUPPRESSIVE COSMETIC COMPOSITIONS CONTAINING ALKOXY OR ALKYLBENZYLOXYBENZOIC ACIDS OR SALTS THEREOF Henkel Kommanditgesellschaft auf Aktien (DE) 1991-08-07 EP claimed
EP-4742268-A2 A METHOD OF GENERATING A STATISTICAL MODEL TO DETECT, OR PREDICT THE RISK OF, AN OUTCOME Metabolomic Diagnostics Limited (IE) 2026-05-13 EP disclosed
EP-4211119-B1 2-AMINOQUINAZOLINES AS LRRK2 INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF MERCK SHARP & DOHME LLC (US) 2026-05-13 EP disclosed
US-4224254-A OXIDATION OF AROMATIC ALCOHOLS, SILVER CATALYST BASF AKTIENGESELLSCHAFT (DE) 1980-09-23 US disclosed
EP-0004881-A2 Process for the preparation of aromatic and araliphatic aldehydes BASF Aktiengesellschaft (DE) 1979-10-31 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100307378-A1 CARBAMATE-METHACRYLATE MONOMERS AND THEIR USE IN DENTAL APPLICATIONS CAD, ACMSD, MMAB CA2 222/4885CA1 226/4885ALDH1A1 844/4885
US-20260060286-A1 A COMPOSITION FOR FAT-SOLUBLE VITAMINS AND PROCESS THEREOF PROC, VDR, FABP4 CA2 3886/4885CA1 4246/4885ALDH1A1 1497/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.